PRGN-2012 – Patient Worthy

kalhh / Pixabay

PRGN-2012 Earns EC Orphan Drug Status for the Treatment of Recurrent Respiratory Papillomatosis

Post author:Jessica Lynn
Post published:January 17, 2024
Post category:Recurrent respiratory papillomatosis

In the European Union, Orphan drug designation is granted by the European Commission (EC) to drugs or biologics that are intended to diagnose, prevent, or treat rare conditions. The definition…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More